1209301

Ravi Ganeshappa, M.D. — FEI 3027036066

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 30, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance